Qube Research & Technologies Ltd

Position in SRRK — Scholar Rock Holding Corp

CIK 1729829 LONDON, X0

Position in SRRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$25,505,150

+$23,629,693 QoQ

Shares Held

463,730

+106.0% QoQ

Ownership

0.381%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#48

of 304 holders

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. SRRK ranks #23 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,505,150	463,730	+106.0%	Shares	Sole	2026-08-14
2024-06-30	$1,875,457	225,145	+575.0%	Shares	Sole	2024-08-14
2024-03-31	$592,420	33,357	+472.4%	Shares	Sole	2024-05-14
2023-12-31	$109,566	5,828	-94.2%	Shares	Sole	2024-02-13
2023-03-31	$800,912	100,114	+87.8%	Shares	Sole	2023-05-15
2022-12-31	$482,482	53,313	+207.3%	Shares	Sole	2023-02-14
2022-09-30	$120,228	17,349	-11.4%	Shares	Sole	2022-11-14
2022-06-30	$107,444	19,571	-31.7%	Shares	Sole	2022-08-15
2022-03-31	$369,620	28,675	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.